STAT October 16, 2024
Torie Bosch

‘This is literally the easiest industry to interrupt, to disintermediate, that I’ve ever been involved with,’ he said

If it weren’t for Martin Shkreli, better known as the Pharma Bro, Mark Cuban might not have gone into the drug business.

That’s what he told me in this week’s episode of the “First Opinion Podcast.” He first started speaking with Alex Oshmyansky — the radiologist who would become his co-founder in Mark Cuban Cost Plus Drugs — around when Shkreli was heading to prison....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Pharma, Pharma / Biotech, Trends
Sanofi, expanding in radiopharma, strikes a joint venture deal
Amid Walgreens and CVS Health closures, major retail chains face headwinds
Sage to cut one-third of workforce, streamline drug pipeline
Humanizing Pharmacy: Shifting From Volume to Value for Improved Care and Reduced Pharmacist Burnout
Lexicon sells Viatris rights to cardio drug outside of the U.S. and Europe

Share This Article